Our previous study in subjects with ASD-associated PAH indicated that the potent vasoconstrictor endothelin-1 was associated with the severity of PAH, whereas vasodilators, prostacyclin and nitric oxide were not differential [24]. This evidence concerns the gene EDN1 and atrial septal defect.